Penumbra Inc. (PEN)
NYSE
Closed
Aug 24, 2026
Day's Range
323.4252 wk Range
221.26Overview - PEN - Penumbra Inc.
Key Statistics
Valuation
Enterprise Value
12.30B
P/E (Trailing)
‪79.71‬
P/E (Forward)
‪53.03‬
PEG Ratio
‪-3.39‬
Price / Sales (TTM)
‪8.51‬
Price / Book
‪8.36‬
EV / EBITDA
‪60.24‬
Profitability
Gross Margin
‪67.92%‬
Profit Margin
‪10.67%‬
Operating Margin
‪10.52%‬
Return on Assets
‪6.41%‬
Return on Equity
‪11.37%‬
Ownership
Shares Outstanding
39.38M
Float
38.29M
Short % of Shares Outstanding
‪5.36%‬
Held by Insiders
‪2.90%‬
Held by Institutions
‪88.30%‬
Price stats
Beta
‪0.70‬
50-Day Avg
‪320.02‬
200-Day Avg
‪321.20‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
16 analysts
Average price target
‪$ 361.83‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - PEN - Penumbra Inc.
Peers - PEN - Penumbra Inc.
Peer Comparison
Compared with companies in Medical Devices listed on NYSE.
- PENNYSEPenumbra Inc.12.80BMarket Cap+18.76%52-week change79.71P/E (Trailing)‪10.67%‬Profit Margin
- CVXNYSEChevron Corporation402.65BMarket Cap+22.93%52-week change19.76P/E (Trailing)‪9.83%‬Profit Margin
- ABTNYSEAbbott Laboratories203.16BMarket Cap-13.06%52-week change37.63P/E (Trailing)‪11.64%‬Profit Margin
- SYKNYSEStryker Corporation126.36BMarket Cap-18.65%52-week change34.14P/E (Trailing)‪14.43%‬Profit Margin
- MDTNYSEMedtronic plc119.48BMarket Cap+1.40%52-week change25.03P/E (Trailing)‪13.20%‬Profit Margin
- ICENYSEIntercontinental Exchange, Inc.90.52BMarket Cap-11.10%52-week change22.71P/E (Trailing)‪38.24%‬Profit Margin
- BSXNYSEBoston Scientific Corporation72.99BMarket Cap-108.68%52-week change20.39P/E (Trailing)‪17.49%‬Profit Margin
Profile Summary - PEN - Penumbra Inc.
About
Penumbra Inc. is a prominent player in the healthcare sector, focusing primarily on the development and commercialization of innovative medical devices. Known for its customer-centric approach, the company operates within the specialized field of interventional therapies, particularly in neuro and vascular medical…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
